Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), Department of Biomolecule Modification and Delivery, Campus Berlin-Buch, Robert-Rössle-Str. 10, 13125 Berlin, Germany
Auto-generated profile, based on publicly available information
Mark Alexander Ruben de Geus
Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), Department of Biomolecule Modification and Delivery, Campus Berlin-Buch, Robert-Rössle-Str. 10, 13125 Berlin, Germany
Activation of a cytotoxic T-cell is a complex multi-step process, and tools to study the molecular events and their dynamics that result in T-cell activation in situ and in vivo are scarce. Here, we report the design and use of conditional epitopes for time-controlled T-cell activation in vivo. We show that trans-cyclooctene-protected SIINFEKL (with the lysine amine masked) is unable to elicit the T-cell response characteristic for free SIINFEKL epitope. Epitope uncaging by means of an inverse-electron demand Diels-Alder (IEDDA) event restored T-cell activation and provided temporal control of T-cell proliferation in vivo.
3 June 2023 in Journal of the American Chemical Society
Bioorthogonal deprotections are readily used to control biological function in a cell-specific manner. To further improve the spatial resolution of these reactions, we here present a lysosome-targeted tetrazine for an organelle-specific deprotection reaction. We show that trans-cyclooctene deprotection with this reagent can be used to control the biological activity of ligands for invariant natural killer T cells in the lysosome to shed light on the processing pathway in antigen presenting cells. We then use the lysosome-targeted tetrazine to show that long peptide antigens used for CD8+ T cell activation do not pass through this organelle, suggesting a role for the earlier endosomal compartments for their processing.